Cargando…
Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
Hypoglycaemia remains the most common metabolic adverse effect of insulin and sulfonylurea therapy in diabetes. Repeated exposure to hypoglycaemia leads to a change in the symptom complex that characterises hypoglycaemia, culminating in a clinical phenomenon referred to as impaired awareness of hypo...
Autores principales: | McNeilly, Alison D., McCrimmon, Rory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448989/ https://www.ncbi.nlm.nih.gov/pubmed/29417183 http://dx.doi.org/10.1007/s00125-018-4548-8 |
Ejemplares similares
-
High‐intensity training as a novel treatment for impaired awareness of hypoglycaemia in type 1 diabetes [HIT4HYPOS]: Protocol for a randomized parallel‐group study
por: Farrell, Catriona M., et al.
Publicado: (2020) -
Clinical approaches to treat impaired awareness of hypoglycaemia
por: Farrell, Catriona M., et al.
Publicado: (2021) -
A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study
por: Farrell, Catriona M., et al.
Publicado: (2020) -
Consequences of recurrent hypoglycaemia on brain function in diabetes
por: McCrimmon, Rory J.
Publicado: (2021) -
Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes
por: McCrimmon, Rory J.
Publicado: (2022)